control group:Febuxostat+Basic treatment

2 trials

Sponsors

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Conditions

hyperuricemic nephropathy at CKD stages 3-4

Unknown Phase

A randomized controlled trial evaluating the jiangniaosuan formulation as a treatment for hyperuricemic nephropathy at CKD stages 3-4 patients

Active, not recruitingChiCTR2100049048

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicinehyperuricemic nephropathy at CKD stages 3-4

Start: 2021-07-20Updated: 2022-04-04

A randomized controlled trial evaluating the jiangniaosuan formulation as a treatment for hyperuricemic nephropathy at CKD stages 3-4 patients

Active, not recruitingITMCTR2100005088

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicinehyperuricemic nephropathy at CKD stages 3-4

Start: 2021-07-20Updated: 2023-02-20